Buyout Bid Overshadows NxStage Medical's Losses

Buyout Bid Overshadows NxStage Medical's Losses


Even though some investors had recently started to worry about the prospects for fast growth from the company , NxStage got a huge vote of confidence from Fresenius Medical Care Coming into Monday's second-quarter financial report, NxStage investors had no inkling that a merger would be right around the corner, and they had mixed expectations about how much growth the medical device maker would be able to produce. NxStage's numbers were a bit disappointing, but all that is likely to pale in comparison to the importance of the proposed acquisition.



from Biotech News